BTCC / BTCC Square / Global Cryptocurrency /
Venture Capital Resurgence in Biotech Sparks Investment Debate

Venture Capital Resurgence in Biotech Sparks Investment Debate

Published:
2025-08-07 01:05:01
19
3
BTCCSquare news:

Biotech funding has surged past pre-pandemic levels, with venture capital investments reaching $21.4 billion in 2024—a 33% year-over-year increase. The sector's rebound mirrors crypto's institutional adoption phase, where capital inflows precede price discovery.

Viking Therapeutics and Eli Lilly emerge as focal points in the biotech valuation debate. Like comparing layer-1 blockchains, their pipelines represent divergent approaches: Viking's targeted therapies versus Lilly's broad infrastructure. Market sentiment now favors specialized assets, echoing crypto's shift from blue chips to high-beta altcoins.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users